{
    "SPADE_UN_22866": {
        "Sequence Information": {
            "Peptide Name": "Ves-CP-M [[IL,L13Y], TempY",
            "Sequence": "FLPLIGKLLSGLY",
            "Sequence Length": 13,
            "Biological Activity": [
                "Anti-Gram+",
                "Anticancer",
                "Anti-Mammalian Cell"
            ],
            "Binding Target": "1. Lipid Bilayer",
            "Source": "",
            "Gene": "",
            "PDB ID": "",
            "UniProt Entry": [
                {
                    "uniprotId": "P17232",
                    "uniprotUrl": "http://www.uniprot.org/uniprot/P17232",
                    "description": "The amino acid sequence of the current peptide coincides with the amino acid sequence of the UniProt entry."
                },
                {
                    "uniprotId": "A0SPI1",
                    "uniprotUrl": "http://www.uniprot.org/uniprot/A0SPI1",
                    "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that represents a peptide precursor."
                }
            ],
            "Literature": [
                {
                    "Title": "Two Novel Anticancer Peptides from Aurein 1.2",
                    "Pubmed ID": "",
                    "Reference": "Int J Pept Res Ther. 2011;17:159–164",
                    "Author": "Shahrbanoo K, Naderi-Manesh H",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/"
                }
            ],
            "Mass": 1433.78,
            "PI": 8.59,
            "Net Charge": 1,
            "Hydrophobicity": 1.38,
            "Frequent Amino Acids": "LGF",
            "Absent Amino Acids": "ACDEHMNOQRTUVW",
            "Basic Residues": 1,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 7,
            "Polar Residues": 6,
            "Positive Residues": 1,
            "Negative Residues": 0,
            "SPADE ID": "SPADE_UN_22866",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_04621",
                    "Similarity": 1.0,
                    "Sequence": "GLYKRLFKKLLKS"
                },
                {
                    "SPADE_ID": "SPADE_N_15791",
                    "Similarity": 0.9090909090909091,
                    "Sequence": "FLPIIGKLLSG"
                },
                {
                    "SPADE_ID": "SPADE_N_09485",
                    "Similarity": 0.8888888888888888,
                    "Sequence": "FLPLAMALGKLL"
                }
            ],
            "Hemolytic Activity": "Human erythrocytes:2% Hemolysis=50 µg/ml,Human erythrocytes:3% Hemolysis=100 µg/ml",
            "Target Organism": "Staphylococcus aureus MR(MIC=30µg/ml),Bacillus cereus ATCC 1015(MIC=30µg/ml),Staphylococcus epidermidis ATCC 1114(MIC=30µg/ml),Leuconostoc mesenteroides ATCC 1059(MIC=10µg/ml),Human breast adenocarcinoma MCF-7(30-40% Killing=20µg/ml),Human breast adenocarcinoma MCF-7(60-70% Killing=30µg/ml),Human lung carcinoma A549(30-40% Killing=20µg/ml),Human lung carcinoma A549(50-60% Killing=30µg/ml)"
        }
    }
}